文献速递艾滋病与性传播感染

HIV 感染后 1 年内启动 ART 可降低非艾滋病定义恶性肿瘤风险

Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk.
PubMed 文献 · Clin Infect Dis · 2026-01-01

荷兰 ATHENA 全国队列纳入 2000–2022 年启动 ART 的 HIV 成人感染者,比较感染后 1 年内启动 ART 与较晚启动者的非艾滋病定义恶性肿瘤(NADM)风险。早启动组 NADM 发生率 2.22/1000 人年,晚启动组 4.87/1000 人年;早启动与任何 NADM 及感染无关 NADM 风险降低相关,校正社会经济地位后结果基本不变。

要点

  • 感染后 1 年内启动 ART 者任何 NADM 风险降低(HR=0.60)。
  • 感染无关 NADM 风险同样降低(HR=0.60),感染相关 NADM 未见显著降低。
  • 早启动组更年轻且最低 CD4 计数更高,解读需注意基线差异。

核心结论

  • 与较晚启动 ART 相比,HIV 感染后 1 年内启动 ART 与 NADM 风险降低相关。
  • 校正社会经济地位后,风险比仅轻微变化。

研究设计与样本

  • 荷兰全国 ATHENA 队列,纳入≥18 岁、2000–2022 年启动 ART 且随访≥6 个月的 HIV 感染者。
  • 早启动 ART 定义为阴性 HIV 检测或原发性 HIV 感染后<365 天启动,其余为晚启动。
  • 采用 Cox 回归估计 NADM 风险比,校正预设混杂因素及社会经济地位。

主要发现

  • NADM 在早启动组诊断 25 例、晚启动组 869 例,发生率分别为 2.22/1000 人年(95%CI=1.50-3.28)和 4.87/1000 人年(95%CI=4.56-5.21)。

临床怎么用

  • 对新诊断 HIV 感染者应尽早启动 ART,以降低 NADM 风险。
  • 风险评估与随访中可关注启动 ART 时机及最低 CD4 计数等基线特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Starting antiretroviral treatment (ART) at higher CD4 cell counts is associated with reduced non-AIDS-defining malignancy (NADM) risk. We studied whether starting ART within 1 year after acquiring human immunodeficiency virus type 1 (HIV-1) reduces this risk while also adjusting for socioeconomic status. METHODS: We included individuals (≥18 years) from the Dutch national ATHENA cohort diagnosed with human immunodeficiency virus (HIV) and having started ART between 2000 and 2022 without prior NADM with ≥6 months of follow-up. "Early ART" initiators were defined as starting ART <365 days following a negative HIV test or primary HIV infection, all others as "late-ART" starters. Hazard ratios (HR) for NADM were estimated using Cox regression, adjusted for a priori selected confounders (age, sex at birth, smoking, alcohol use, calendar time, HIV transmission route, region of origin, nadir CD4 cell count, HIV-1 viral copy-years), and socioeconomic status (SES) using data from Statistics Netherlands. RESULTS: Compared to "late-ART" (n = 17 965) participants, "early-ART" participants (n = 1858) were younger (median 34.8 vs 39.0 years), with a higher nadir CD4 count (median 478 vs 260 cells/µL). NADM were diagnosed in 25 "early-ART" and 869 "late-ART" starters resulting in an incidence rate of 2.22/1000 person-years (PY) (95% confidence interval [CI] = 1.50-3.28) and 4.87/1000 PY (95% CI = 4.56-5.21), respectively. "Early-ART" initiation was associated with a reduced risk of any NADM (HR = 0.60 [95% CI = .40-.91]) and infection-unrelated NADM (HR = 0.60 [95% CI = .37-.98]), but not of infection-related NADM (HR = 0.58 [95% CI = .27-1.28]). Additional adjustment for SES only minimally changed the hazard ratios. CONCLUSIONS: Starting ART within 1 year of HIV acquisition is associated with a reduced NADM risk compared to starting ART later.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. van der Wulp IAJ, Wit FWNM, Jongen VW, et al. Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk. Clin Infect Dis. 2026. PMID: 41206033. doi:10.1093/cid/ciaf595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。